The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.
Poll finds less than 1 in 3 people over 50 currently use them for any purpose, and only 28% of people with diabetes use them to track blood sugar levels.
Older adults got less diabetes and cholesterol screening when their primary care practice or health system left the Shared Savings Program.
In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.
For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.